Bibliographic Details
| Title: |
A Case of Immune-Related Aseptic Meningitis during Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma. |
| Authors: |
Kawanaka, Hiroki, Tajiri, Kazuto, Muraishi, Nozomu, Murayama, Aiko, Nukui, Takamasa, Yasuda, Ichiro |
| Source: |
Case Reports in Gastroenterology; 2024, Vol. 18 Issue 1, p8-13, 6p |
| Subject Terms: |
CONTRAST-enhanced magnetic resonance imaging, DRUG side effects, CEREBROSPINAL fluid examination, CEREBRAL sulci, ATEZOLIZUMAB, HEPATOCELLULAR carcinoma |
| Abstract: |
Introduction: Immune checkpoint inhibitors are sometimes associated with immune-related adverse events during or after treatment. Among these, aseptic meningitis is a rare and serious complication. We report the first case of atezolizumab-induced aseptic meningitis, which occurred during treatment for advanced hepatocellular carcinoma (HCC). Case Presentation: A 74-year-old woman diagnosed with advanced HCC and treated with first-line atezolizumab plus bevacizumab developed anorexia, fatigue, and fever, after three treatment cycles. Cerebrospinal fluid examination showed slightly increased cell count and protein level but no infection or malignancy. Contrast enhancement along the cerebral sulcus was evident in contrast-enhanced magnetic resonance imaging, and the patient was diagnosed with aseptic meningitis associated with atezolizumab. Steroid therapy soon improved her clinical symptoms, and the contrast enhancement along the cerebral sulcus disappeared. Conclusion: Clinicians should monitor to avoid serious immune-related adverse events, such as aseptic meningitis, in patients during treatment of HCC with immune checkpoint inhibitors and make the diagnosis as soon as possible. [ABSTRACT FROM AUTHOR] |
|
Copyright of Case Reports in Gastroenterology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
